Original article
Assessment of eotaxin 1 in exhaled breath condensate of chronic obstructive pulmonary disease patients

https://doi.org/10.1016/j.ejcdt.2013.11.006Get rights and content
Under a Creative Commons license
open access

Abstract

The aim of this work was to assess eotaxin 1 level in exhaled breath condensate of exacerbated and stable COPD patients in relation to normal subjects.

Subjects and methods

There were 16 COPD patients (during infective exacerbation), 16 stable COPD patients and 20 healthy volunteers as controls matched with them in age, sex and smoking history. EBC was collected and concentration of eotaxin 1 was measured by using Human Eotaxin 1 ELISA Kits.

Results

The mean eotaxin 1 concentration in exhaled breath condensate of studied groups was 962.5 ± 150 pg/ml in the exacerbated COPD group, 427.8 ± 186.6 pg/ml in the stable group and 89.2 ± 47.5 pg/ml in the control group. Age, smoking, FVC, FEV1, and FEV1/FVC, showed no significant correlation with eotaxin 1 levels among all the studied groups.

Conclusion

Eotaxin 1 levels in exhaled breath condensate of COPD patients during infective exacerbation was significantly higher than in stable COPD patients and both groups showed significant higher levels than the control group.

Abbreviations

COPD
chronic obstructive pulmonary disease
EBC
exhaled breath condensate
IL
interleukin
Th
T-helper cells
FVC
forced vital capacity
FEV1
forced expiratory volume in first second
CCR3
c chemokine receptor 3

Keywords

COPD
Eotaxin 1
Exhaled breath condensate
Eosinophil chemoattractant

Cited by (0)

Peer review under responsibility of The Egyptian Society of Chest Diseases and Tuberculosis.

  1. Download : Download full-size image